Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Return on Equity (2020 - 2025)

Historic Return on Equity for Pulmonx (LUNG) over the last 6 years, with Q3 2025 value amounting to 0.88%.

  • Pulmonx's Return on Equity fell 2900.0% to 0.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.88%, marking a year-over-year decrease of 2900.0%. This contributed to the annual value of 0.55% for FY2024, which is 1100.0% down from last year.
  • According to the latest figures from Q3 2025, Pulmonx's Return on Equity is 0.88%, which was down 2900.0% from 0.78% recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Return on Equity ranged from a high of 0.17% in Q1 2021 and a low of 0.88% during Q3 2025
  • For the 5-year period, Pulmonx's Return on Equity averaged around 0.45%, with its median value being 0.44% (2023).
  • Over the last 5 years, Pulmonx's Return on Equity had its largest YoY gain of 31100bps in 2021, and its largest YoY loss of -3500bps in 2021.
  • Pulmonx's Return on Equity (Quarter) stood at 0.25% in 2021, then crashed by -51bps to 0.37% in 2022, then crashed by -34bps to 0.5% in 2023, then dropped by -26bps to 0.63% in 2024, then crashed by -40bps to 0.88% in 2025.
  • Its Return on Equity was 0.88% in Q3 2025, compared to 0.78% in Q2 2025 and 0.7% in Q1 2025.